ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2037

Assessing Risk of Depression in Common Rheumatologic Disorders Using Diagnostic Codes, Survey Scores, and Propensity Score Matching Methodology

COMFORT ANIM-KORANTENG1, YONG EUN2, Okeoghene Akpoigbe2 and AMANDA SAMMUT2, 1Harlem Hospital Center, New York, NY, 2NYCHH- HARLEM, New York, NY

Meeting: ACR Convergence 2023

Keywords: autoimmune diseases, depression, dermatomyositis, fibromyalgia, Scleroderma, Systemic

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (2019–2038) Patient Outcomes, Preferences, & Attitudes Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Many studies have shown that rheumatologic conditions are associated with a higher risk of depression. The two most common methods to detect depression in these studies used DSM/ICD criteria; alternatively, self-report screening questionnaires, such as the Patient Health Questionnaire (PHQ). However, using one or the other method to detect depression might lead to decreased sensitivity to detect depression, and the statistical analysis can be fraught with difficulty since numerous confounding variables affect depression. In this study, we aim to implement both methods to detect depression in patients with Systemic sclerosis (SSc), Dermatomyositis (DM), and Fibromyalgia(FM) using propensity-score matching in a national cohort database.

Methods: ICD 9/10 codes were used to identify SSc, DM, and FM, of which a propensity score matching (PSM) analysis was used to evaluate the effect of disease on the risk of developing depression in a cohort of 240,353 Americans enrolled in the “All of Us database.” ICD 9/10 codes were used, and it can be inferred that the ACR classification criteria for the diseases were met. Covariates for matching included age, gender, race, ethnicity, income level, education level, marital status, cigarette exposure, alcohol exposure, drug exposure, and comorbidities. The control groups were matched with a ratio of 1 to each patient group based on propensity scores. The PSM reduces any confounding factors between the case and control cohorts. A logistic regression analysis determined the association between each disorder and depression. Global Mental Health Scores (GMHS) were compared between control and disease groups using a t-test or Mann-Whitney U test. GMHS is a patient-reported perspective of their mental health, with a score range of 0-20, with the maximum score representing optimum health status.

Results: Out of 240,353 individuals, 638 patients with SSc, 358 patients with DM, and 21,263 FM patients were identified. Control groups for each disease were statistically not different (p ≥0.05) from the case groups for age, gender, race, ethnicity, income level, education level, marital status, cigarette exposure, alcohol exposure, drug exposure, and Charlson comorbidity scores. Only FM was associated with increased risk of depression (OR 2.32 [95% CI: 2.23-2.41], p< 0.001), which was in line with the lower average GMHS of FM patients (13.1) compared to control (13.8) (p< 0.001). SSc (OR 0.94, 95% CI: 0.75-1.17, p=0.571) and DM (OR 1.07, 95% CI: 0.80-1.44, p=0.649) were not associated with an increased risk of depression. The average GMHS of SSc (13.6) and DM (13.4) patients were statistically not different from their respective control groups.

Conclusion: When used concurrently, diagnostic codes for depression and self-reported screening questionnaires were congruent in assessing the association of depression with common rheumatologic disorders. In addition, the use of propensity score matching helped eliminate confounding variables.


Disclosures: C. ANIM-KORANTENG: None; Y. EUN: None; O. Akpoigbe: None; A. SAMMUT: None.

To cite this abstract in AMA style:

ANIM-KORANTENG C, EUN Y, Akpoigbe O, SAMMUT A. Assessing Risk of Depression in Common Rheumatologic Disorders Using Diagnostic Codes, Survey Scores, and Propensity Score Matching Methodology [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/assessing-risk-of-depression-in-common-rheumatologic-disorders-using-diagnostic-codes-survey-scores-and-propensity-score-matching-methodology/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/assessing-risk-of-depression-in-common-rheumatologic-disorders-using-diagnostic-codes-survey-scores-and-propensity-score-matching-methodology/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology